State Street Corp Cel Sci Corp Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Cel Sci Corp stock. As of the latest transaction made, State Street Corp holds 193,507 shares of CVM stock, worth $147,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,507

Previous 194,007 0.26%

Holding current value

$147,065

Previous $370,000 39.46%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.11 - $1.85 $555 - $925	-500 Reduced 0.26%	193,507 $224,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $3.07 $42,372 - $121,572	39,600 Added 25.65%	194,007 $527,000
Q3 2023 Nov 14, 2023	SELL	$1.17 - $2.86 $19,422 - $47,476	-16,600 Reduced 9.71%	154,407 $193,000
Q2 2023 Aug 14, 2023	SELL	$2.11 - $2.83 $33,127 - $44,431	-15,700 Reduced 8.41%	171,007 $412,000
Q1 2023 May 15, 2023	SELL	$2.17 - $3.13 $68,355 - $98,595	-31,500 Reduced 14.44%	186,707 $433,000
Q4 2022 Feb 14, 2023	BUY	$1.99 - $3.52 $5,572 - $9,856	2,800 Added 1.3%	218,207 $512,000
Q3 2022 Nov 15, 2022	SELL	$3.09 - $5.23 $119,583 - $202,401	-38,700 Reduced 15.23%	215,407 $666,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $1.87 Million - $3.62 Million	-726,232 Reduced 74.08%	254,107 $1.14 Million
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $9.39 Million - $18.4 Million	-2,388,659 Reduced 70.9%	980,339 $3.85 Million
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $8.57 Million - $15.5 Million	-1,207,726 Reduced 26.39%	3,368,998 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $13.6 Million - $22.2 Million	1,775,228 Added 63.37%	4,576,724 $50.3 Million
Q2 2021 Aug 16, 2021	BUY	$8.68 - $27.49 $61,280 - $194,079	7,060 Added 0.25%	2,801,496 $24.3 Million
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $9.79 Million - $22.6 Million	815,957 Added 41.24%	2,794,436 $42.5 Million
Q4 2020 Feb 16, 2021	BUY	$11.05 - $16.62 $2.08 Million - $3.12 Million	187,803 Added 10.49%	1,978,479 $23.1 Million
Q3 2020 Nov 10, 2020	SELL	$11.69 - $14.54 $8.95 Million - $11.1 Million	-765,301 Reduced 29.94%	1,790,676 $22.8 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $19.4 Million - $34.9 Million	1,984,645 Added 347.37%	2,555,977 $38.1 Million
Q1 2020 May 11, 2020	BUY	$7.54 - $17.05 $4.31 Million - $9.74 Million	571,332 New	571,332 $6.59 Million

Others Institutions Holding CVM

# of Institutions

Shares Held

6.23M

Call Options Held

16.6K

Put Options Held

148K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $33M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cel Sci Corp Transaction History